Pages that link to "Q36229313"
Jump to navigation
Jump to search
The following pages link to Breast cancer instructs dendritic cells to prime interleukin 13-secreting CD4 T cells that facilitate tumor development (Q36229313):
Displaying 50 items.
- Tumor-Associated Macrophages and Neutrophils in Tumor Microenvironment (Q26766429) (← links)
- Myeloid Cells as Targets for Therapy in Solid Tumors (Q26801832) (← links)
- CD4 /CD8 double-positive T cells: more than just a developmental stage? (Q26821885) (← links)
- Neutralizing tumor-promoting chronic inflammation: a magic bullet? (Q26830931) (← links)
- Dendritic cell-targeted approaches to modulate immune dysfunction in the tumor microenvironment (Q27000318) (← links)
- Understanding dendritic cells and their role in cutaneous carcinoma and cancer immunotherapy (Q27004702) (← links)
- Concise review: humanized models of tumor immunology in the 21st century: convergence of cancer research and tissue engineering (Q27022477) (← links)
- Carcinoma-derived interleukin-8 disorients dendritic cell migration without impairing T-cell stimulation (Q27349546) (← links)
- Immunity, Inflammation, and Cancer (Q27861048) (← links)
- The efficacy of radiotherapy relies upon induction of type i interferon-dependent innate and adaptive immunity (Q28304923) (← links)
- Diet-induced obesity alters dendritic cell function in the presence and absence of tumor growth (Q28386614) (← links)
- Val-boroPro accelerates T cell priming via modulation of dendritic cell trafficking resulting in complete regression of established murine tumors (Q28395507) (← links)
- Cancer immunotherapy via dendritic cells (Q29615444) (← links)
- Taking dendritic cells into medicine (Q29619243) (← links)
- Reprogramming tumor-infiltrating dendritic cells for CD103 CD8 mucosal T-cell differentiation and breast cancer rejection (Q33581986) (← links)
- Elimination of IL-10-inducing T-helper epitopes from an IGFBP-2 vaccine ensures potent antitumor activity. (Q33679779) (← links)
- Acute inflammation induced by the biopsy of mouse mammary tumors promotes the development of metastasis (Q33683707) (← links)
- Lymphocytes in cancer development: polarization towards pro-tumor immunity (Q33712435) (← links)
- Tumor-infiltrating regulatory dendritic cells inhibit CD8 T cell function via L-arginine metabolism. (Q33763653) (← links)
- Induction of Th1Immune responses following laser ablation in a murine model of colorectal liver metastases (Q33914458) (← links)
- Human hemato-lymphoid system mice: current use and future potential for medicine (Q33995307) (← links)
- Pattern response of dendritic cells in the tumor microenvironment and breast cancer (Q34023724) (← links)
- Cancer and inflammation: promise for biologic therapy. (Q34139732) (← links)
- Designing Vaccines Based on Biology of Human Dendritic Cell Subsets (Q34289152) (← links)
- AllergoOncology: the role of IgE-mediated allergy in cancer (Q34394208) (← links)
- Leukocytes in Mammary Development and Cancer (Q34578021) (← links)
- Optimizing dendritic cell-based approaches for cancer immunotherapy (Q34637535) (← links)
- Dendritic cell-based vaccines: barriers and opportunities (Q34661797) (← links)
- Thymic stromal lymphopoietin fosters human breast tumor growth by promoting type 2 inflammation (Q34681491) (← links)
- CD4( ) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages (Q34995099) (← links)
- Unique Ectopic Lymph Node-Like Structures Present in Human Primary Colorectal Carcinoma Are Identified by Immune Gene Array Profiling (Q35070183) (← links)
- Peptide-pulsed dendritic cells have superior ability to induce immune-mediated tissue destruction compared to peptide with adjuvant (Q35125382) (← links)
- Tumor-associated macrophages regulate tumorigenicity and anticancer drug responses of cancer stem/initiating cells (Q35134007) (← links)
- Platinum-based drugs disrupt STAT6-mediated suppression of immune responses against cancer in humans and mice (Q35142813) (← links)
- The role of complement in tumor growth (Q35231345) (← links)
- Profile of differentially expressed intratumoral cytokines to predict the immune-polarizing side effects of tamoxifen in breast cancer treatment (Q35402584) (← links)
- Interleukin-13 is overexpressed in cutaneous T-cell lymphoma cells and regulates their proliferation (Q35584244) (← links)
- Leukocyte composition of human breast cancer (Q35779386) (← links)
- Programmed death ligand 2 in cancer-induced immune suppression. (Q35955151) (← links)
- The differential production of cytokines by human Langerhans cells and dermal CD14( ) DCs controls CTL priming (Q36057590) (← links)
- Capturing and characterizing immune cells from breast tumor microenvironment: an innovative surgical approach. (Q36109399) (← links)
- TSLP Expression and High Serum TSLP Level Indicate a Poor Prognosis in Gastric Cancer Patients (Q36225603) (← links)
- Trial watch: Dendritic cell-based interventions for cancer therapy (Q36388529) (← links)
- IKKβ/NFκBp65 activated by interleukin-13 targets the autophagy-related genes LC3B and beclin 1 in fibroblasts co-cultured with breast cancer cells (Q36740894) (← links)
- Tissue-resident dendritic cells and diseases involving dendritic cell malfunction (Q36786334) (← links)
- Inflammation-associated lysophospholipids as ligands for CD1d-restricted T cells in human cancer (Q36835186) (← links)
- Interactions of tumor cells with dendritic cells: balancing immunity and tolerance (Q36975749) (← links)
- Cysteine cathepsin non-inhibitory binding partners: modulating intracellular trafficking and function (Q36988314) (← links)
- Taming cancer by inducing immunity via dendritic cells (Q36990604) (← links)
- Prognostic value of single nucleotide polymorphisms of candidate genes associated with inflammation in early stage breast cancer (Q37104237) (← links)